Copyright Reports & Markets. All rights reserved.

Global and Japan Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 CTCs
    • 1.2.3 CtDNA
    • 1.2.4 Exosomes And RNA
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Physicians' Office Laboratories
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2015-2026)
  • 2.2 Global Lung Cancer Liquid Biopsy Growth Trends by Regions
    • 2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lung Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Lung Cancer Liquid Biopsy Players by Market Size
    • 3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2015-2020)
    • 3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
  • 3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
    • 3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2019
  • 3.5 Key Players Lung Cancer Liquid Biopsy Area Served
  • 3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
  • 3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type (2015-2026)

  • 4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
  • 4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application (2015-2026)

  • 5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2015-2020)
  • 5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lung Cancer Liquid Biopsy Market Size (2015-2026)
  • 6.2 North America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 6.3 North America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 6.4 North America Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Lung Cancer Liquid Biopsy Market Size (2015-2026)
  • 7.2 Europe Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 7.3 Europe Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Lung Cancer Liquid Biopsy Market Size (2015-2026)
  • 8.2 China Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 8.3 China Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 8.4 China Lung Cancer Liquid Biopsy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Lung Cancer Liquid Biopsy Market Size (2015-2026)
  • 9.2 Japan Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 9.3 Japan Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 9.4 Japan Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Lung Cancer Liquid Biopsy Market Size (2015-2026)
  • 10.2 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Biocept
    • 11.1.1 Biocept Company Details
    • 11.1.2 Biocept Business Overview
    • 11.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
    • 11.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2015-2020))
    • 11.1.5 Biocept Recent Development
  • 11.2 Exosome Diagnostics
    • 11.2.1 Exosome Diagnostics Company Details
    • 11.2.2 Exosome Diagnostics Business Overview
    • 11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
    • 11.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.2.5 Exosome Diagnostics Recent Development
  • 11.3 F. Hoffmann-La Roche
    • 11.3.1 F. Hoffmann-La Roche Company Details
    • 11.3.2 F. Hoffmann-La Roche Business Overview
    • 11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
    • 11.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.3.5 F. Hoffmann-La Roche Recent Development
  • 11.4 Qiagen
    • 11.4.1 Qiagen Company Details
    • 11.4.2 Qiagen Business Overview
    • 11.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
    • 11.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.4.5 Qiagen Recent Development
  • 11.5 Accuragen
    • 11.5.1 Accuragen Company Details
    • 11.5.2 Accuragen Business Overview
    • 11.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
    • 11.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.5.5 Accuragen Recent Development
  • 11.6 Agena Bioscience
    • 11.6.1 Agena Bioscience Company Details
    • 11.6.2 Agena Bioscience Business Overview
    • 11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
    • 11.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.6.5 Agena Bioscience Recent Development
  • 11.7 Bard1
    • 11.7.1 Bard1 Company Details
    • 11.7.2 Bard1 Business Overview
    • 11.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
    • 11.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.7.5 Bard1 Recent Development
  • 11.8 Bgi
    • 11.8.1 Bgi Company Details
    • 11.8.2 Bgi Business Overview
    • 11.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
    • 11.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
    • 11.8.5 Bgi Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Lung Cancer Liquid Biopsy Scope and Market Size
    Lung Cancer Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    CTCs
    CtDNA
    Exosomes And RNA
    Others

    Market segment by Application, split into
    Clinics
    Hospitals
    Physicians' Office Laboratories

    Based on regional and country-level analysis, the Lung Cancer Liquid Biopsy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Lung Cancer Liquid Biopsy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Biocept
    Exosome Diagnostics
    F. Hoffmann-La Roche
    Qiagen
    Accuragen
    Agena Bioscience
    Bard1
    Bgi

    Buy now